arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Candel Therapeutics, Inc.

CADL Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$8.05
▼ -3.8% Today
as of Oct 23, 11:16 ET
Last 30 days -24.64% Sep 14 → Oct 23
$7.74 $8.84 $9.95 $11.05 $12.15 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$8.45
High
$8.79
Low
$8.26
Volume
$754,010
Avg Vol
$1M
Mkt Cap
$777M
P/E (TTM)
—
Beta
—
52w High
$14.00
52w Low
$4.35
Div Yield
—
Shares Out
$76M

Recent Press Releases & News last 60 days · 14 items

Oct 22 · 12:05 PR GlobeNewswire
Candel Therapeutics Appoints Maria Ostrovsky as General Counsel
Oct 2 · 13:00 PR GlobeNewswire
Candel Therapeutics to Present at the SITC 2026 Annual Meeting
Oct 1 · 20:05 PR GlobeNewswire
Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
▸ Show all 14 press releases & news Free account →

CADL earnings at a glance

The options market is pricing a move of about ±12.9% after the report, a range of roughly $7.01 to $9.09 from today's $8.05. Over its last 2 reports the stock rose the next day 1 time and fell 1, moving ±4.0% on average; after the most recent report on May 14, 2026 it moved -0.3%. That means options currently expect more movement than CADL has typically delivered. CADL beat the consensus EPS estimate in 3 of its last 4 reported quarters. Implied volatility is currently 110%. The share price of $8.05 sits in the middle of its 52-week range.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$4.35
$14
38% of range
Avg surprise (last 4)
+53.5%
Avg reaction (last 2)
+3.7%
50% positive
Latest IV / EM
110%
EM ±12.9% · $10 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.74$-0.52$-0.30$-0.09$0.13 Actual $-0.30Actual $-0.33Actual $-0.29Actual $-0.28Actual $-0.74Actual $-0.33Actual $0.13Est $-0.24Actual $-0.09Est $-0.17Actual $-0.21Est $-0.17Actual $-0.14Est $-0.22Actual $-0.52 MarJunSepMarJunSepMar/2025Jun/2025Sep/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-39M$-27M$-16M$-4M$8M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.52 — — — — financials
Thu May 14, 2026Mar/2026 $-0.14 $-0.22 +36.4% -207.7% -0.3% earnings
Thu Nov 13, 2025Sep/2025 $-0.21 $-0.17 -23.5% — — earnings
Thu Aug 14, 2025Jun/2025 $-0.09 $-0.17 +47.1% — — earnings
Tue May 13, 2025Mar/2025 $0.13 $-0.24 +154.2% — +7.7% earnings
Mon Sep 30, 2024Sep 2024 $-0.33 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.74 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.28 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.29 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.33 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.30 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue————————
Cost of revenue————————
Gross profit————————
Operating income$-27M$-16M—$-13M$-11M$-8M—$-9M
Net income$-39M$-9M—$-11M$-5M$7M—$-11M
EPS (diluted)$-0.52$-0.14—$-0.21$-0.09$0.13—$-0.33

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$202M$195M$120M$87M$101M$92M$103M$17M
Inventory————————
Total current assets$204M$198M$121M$90M$104M$93M$104M$18M
Total assets$208M$202M$125M$94M$106M$96M$107M$22M
Long-term debt———————$4M
Total liabilities$82M$64M$73M$13M$16M$21M$41M$37M
Total equity$126M$138M$52M$80M$90M$75M$66M$-15M

Implied volatility — last 90 days

53%191%330%469%608% Jun 07 — IV 310% · EM ±42.9%Jun 08 — IV 180% · EM ±23.8%Jun 09 — IV 111% · EM ±14.0%Jun 10 — IV 137% · EM ±16.2%Jun 11 — IV 214% · EM ±23.6%Jun 12 — IV 571% · EM ±58.4%Jun 15 — IV 160% · EM ±11.6%Jun 16 — IV 276% · EM ±16.3%Jun 17 — IV 390% · EM ±16.3%Jun 19 — IV 133% · EM ±29.5%Jun 22 — IV 74% · EM ±15.4%Jun 23 — IV 199% · EM ±40.7%Jun 24 — IV 280% · EM ±56.1%Jun 25 — IV 151% · EM ±29.6%Jun 29 — IV 133% · EM ±23.6%Jul 01 — IV 67% · EM ±11.2%Jul 02 — IV 113% · EM ±18.3%Jul 03 — IV 117% · EM ±18.3%Jul 06 — IV 353% · EM ±48.9%Jul 07 — IV 417% · EM ±55.0%Jul 08 — IV 441% · EM ±55.2%Jul 10 — IV 510% · EM ±56.4%Jul 13 — IV 87% · EM ±7.3%Jul 16 — IV 354% · EM ±14.8%Jul 20 — IV 221% · EM ±52.2%Jul 21 — IV 105% · EM ±24.5%Jul 22 — IV 104% · EM ±23.8%Jul 23 — IV 161% · EM ±36.3%Jul 24 — IV 115% · EM ±25.4%Jul 27 — IV 111% · EM ±23.1%Jul 29 — IV 151% · EM ±30.3%Jul 30 — IV 89% · EM ±17.5%Jul 31 — IV 128% · EM ±24.5%Aug 03 — IV 126% · EM ±22.3%Aug 04 — IV 274% · EM ±47.1%Aug 05 — IV 177% · EM ±29.6%Aug 06 — IV 301% · EM ±48.7%Aug 07 — IV 186% · EM ±29.0%Aug 10 — IV 122% · EM ±16.9%Aug 11 — IV 96% · EM ±12.7%Aug 12 — IV 374% · EM ±46.8%Aug 13 — IV 223% · EM ±26.4%Aug 14 — IV 66% · EM ±7.3%Aug 17 — IV 128% · EM ±10.7%Aug 19 — IV 609% · EM ±36.0%Aug 20 — IV 89% · EM ±3.7%Aug 24 — IV 186% · EM ±38.9%Aug 26 — IV 121% · EM ±24.3%Aug 27 — IV 54% · EM ±10.5%Aug 28 — IV 131% · EM ±25.1%Aug 31 — IV 216% · EM ±38.3%Sep 03 — IV 238% · EM ±38.6%Sep 09 — IV 328% · EM ±41.1%Sep 21 — IV 106% · EM ±22.1%Sep 22 — IV 156% · EM ±32.0%Sep 23 — IV 122% · EM ±24.4%Sep 24 — IV 82% · EM ±16.0%Sep 25 — IV 78% · EM ±14.9%Sep 28 — IV 108% · EM ±19.2%Sep 29 — IV 176% · EM ±30.3%Sep 30 — IV 163% · EM ±27.3%Oct 01 — IV 55% · EM ±8.9%Oct 02 — IV 68% · EM ±10.6%Oct 06 — IV 53% · EM ±7.0%Oct 07 — IV 98% · EM ±12.2%Oct 08 — IV 110% · EM ±12.9%

Sector peers

FDMT
4D Molecular Therapeutics, Inc.
$765M $11.04-12.6%
SANA
Sana Biotechnology, Inc.
$814M $2.29-2.8%
DNA
Ginkgo Bioworks Holdings, Inc.
$738M $9.73-2.8%
SLDB
Solid Biosciences Inc.
$734M $5.87-8.4%
PRME
Prime Medicine, Inc.
$707M $3.48-8.5%
GLUE
Monte Rosa Therapeutics, Inc.
$868M $10.78-3.9%

CADL earnings FAQ

What is CADL's expected move for earnings?

Options currently price a move of about ±12.9%, or $1.04 per share either way from $8.05.

How does CADL stock usually react to earnings?

Across the last 2 reports the average next-day move was ±4.0%, up 1 times and down 1 times.

What is CADL's implied volatility?

CADL's at-the-money implied volatility is about 110% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in